Association between hyperglycemia at admission and microvascular obstruction in patients with ST-segment elevation

Shingo Ota1, Takashi Tanimoto1, Makoto Orii1

  • 1Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Journal of Cardiology
|December 24, 2014
PubMed

Insights

Admission hyperglycemia in ST-segment elevation myocardial infarction (STEMI) patients is linked to microvascular obstruction (MVO). This finding highlights the importance of blood glucose levels in predicting cardiac outcomes after STEMI.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Endocrinology

Background:

  • Admission blood glucose levels in ST-segment elevation myocardial infarction (STEMI) predict heart failure and mortality.
  • Hyperglycemia is associated with microvascular dysfunction.
  • Late gadolinium enhancement cardiovascular magnetic resonance imaging (LGE-CMR) can identify microvascular obstruction (MVO).

Purpose of the Study:

  • To investigate the association between admission hyperglycemia and MVO in STEMI patients using CMR.

Main Methods:

  • Ninety-three STEMI patients treated with percutaneous coronary intervention (PCI) underwent CMR within 7 days.
  • Plasma glucose levels were measured upon admission before medication.
  • LGE-CMR was used to assess the presence of MVO.

Main Results:

  • MVO was present in 37% of patients.
  • Patients with MVO had significantly higher admission glucose levels (204 mg/dl) compared to those without MVO (157 mg/dl).
  • Admission glucose was an independent predictor of MVO, with a threshold of 190 mg/dl effectively identifying MVO presence.

Conclusions:

  • Admission hyperglycemia in STEMI patients treated with PCI is associated with the presence of MVO.
  • This association was assessed using LGE-CMR.
  • Elevated glucose levels at admission may indicate increased risk for MVO in STEMI.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
8
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
6
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2